Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

shCCL20 Citations (1)

Originally described in: CCL20 mediates lipopolysaccharide induced liver injury and is a potential driver of inflammation and fibrosis in alcoholic hepatitis.
Affo S, Morales-Ibanez O, Rodrigo-Torres D, Altamirano J, Blaya D, Dapito DH, Millan C, Coll M, Caviglia JM, Arroyo V, Caballeria J, Schwabe RF, Gines P, Bataller R, Sancho-Bru P Gut. 2014 Nov;63(11):1782-92. doi: 10.1136/gutjnl-2013-306098. Epub 2014 Jan 10. PubMed Journal

Articles Citing shCCL20

Articles
Recruitment and activation of type 3 innate lymphoid cells promote antitumor immune responses. Bruchard M, Geindreau M, Perrichet A, Truntzer C, Ballot E, Boidot R, Racoeur C, Barsac E, Chalmin F, Hibos C, Baranek T, Paget C, Ryffel B, Rebe C, Paul C, Vegran F, Ghiringhelli F. Nat Immunol. 2022 Feb;23(2):262-274. doi: 10.1038/s41590-021-01120-y. Epub 2022 Jan 31. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.